Equillium, Inc.

NasdaqCM:EQ Stock Report

Market Cap: US$98.0m

Equillium Management

Management criteria checks 4/4

Equillium's CEO is Bruce Steel, appointed in Jan 2006, has a tenure of 19.92 years. total yearly compensation is $684.39K, comprised of 68.9% salary and 31.1% bonuses, including company stock and options. directly owns 6.1% of the company’s shares, worth $5.98M. The average tenure of the management team and the board of directors is 7.9 years and 6.9 years respectively.

Key information

Bruce Steel

Chief executive officer

US$684.4k

Total compensation

CEO salary percentage68.87%
CEO tenure19.9yrs
CEO ownership6.1%
Management average tenure7.9yrs
Board average tenure6.9yrs

Recent management updates

Recent updates

Investors Don't See Light At End Of Equillium, Inc.'s (NASDAQ:EQ) Tunnel

Nov 10
Investors Don't See Light At End Of Equillium, Inc.'s (NASDAQ:EQ) Tunnel

Equillium, Inc.'s (NASDAQ:EQ) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Jul 18
Equillium, Inc.'s (NASDAQ:EQ) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Revenues Working Against Equillium, Inc.'s (NASDAQ:EQ) Share Price Following 47% Dive

Mar 31
Revenues Working Against Equillium, Inc.'s (NASDAQ:EQ) Share Price Following 47% Dive

Equillium, Inc.'s (NASDAQ:EQ) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Feb 12
Equillium, Inc.'s (NASDAQ:EQ) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Why Investors Shouldn't Be Surprised By Equillium, Inc.'s (NASDAQ:EQ) 35% Share Price Plunge

Nov 16
Why Investors Shouldn't Be Surprised By Equillium, Inc.'s (NASDAQ:EQ) 35% Share Price Plunge

Lacklustre Performance Is Driving Equillium, Inc.'s (NASDAQ:EQ) 28% Price Drop

Sep 26
Lacklustre Performance Is Driving Equillium, Inc.'s (NASDAQ:EQ) 28% Price Drop

Benign Growth For Equillium, Inc. (NASDAQ:EQ) Underpins Stock's 54% Plummet

Jun 16
Benign Growth For Equillium, Inc. (NASDAQ:EQ) Underpins Stock's 54% Plummet

We Think Equillium (NASDAQ:EQ) Needs To Drive Business Growth Carefully

May 01
We Think Equillium (NASDAQ:EQ) Needs To Drive Business Growth Carefully

Little Excitement Around Equillium, Inc.'s (NASDAQ:EQ) Revenues

Mar 27
Little Excitement Around Equillium, Inc.'s (NASDAQ:EQ) Revenues

Analyst Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Aug 14
Analyst Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Earnings Release: Here's Why Analysts Cut Their Equillium, Inc. (NASDAQ:EQ) Price Target To US$6.06

Aug 12
Earnings Release: Here's Why Analysts Cut Their Equillium, Inc. (NASDAQ:EQ) Price Target To US$6.06

Broker Revenue Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

May 03
Broker Revenue Forecasts For Equillium, Inc. (NASDAQ:EQ) Are Surging Higher

Does Equillium (NASDAQ:EQ) Have A Healthy Balance Sheet?

Mar 26
Does Equillium (NASDAQ:EQ) Have A Healthy Balance Sheet?

Equillium GAAP EPS of -$0.41 in-line

Aug 15

Equillium CEO Bruce Steel - Drugs For Autoimmune, Inflammatory Disorders (Video)

Oct 08

Is Equillium, Inc.'s (NASDAQ:EQ) Shareholder Ownership Skewed Towards Insiders?

Mar 09
Is Equillium, Inc.'s (NASDAQ:EQ) Shareholder Ownership Skewed Towards Insiders?

How Much Of Equillium, Inc. (NASDAQ:EQ) Do Insiders Own?

Nov 24
How Much Of Equillium, Inc. (NASDAQ:EQ) Do Insiders Own?

CEO Compensation Analysis

How has Bruce Steel's remuneration changed compared to Equillium's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$24m

Jun 30 2025n/an/a

-US$20m

Mar 31 2025n/an/a

-US$14m

Dec 31 2024US$684kUS$471k

-US$8m

Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$8m

Mar 31 2024n/an/a

-US$12m

Dec 31 2023US$1mUS$455k

-US$13m

Sep 30 2023n/an/a

-US$8m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$2mUS$455k

-US$62m

Sep 30 2022n/an/a

-US$76m

Jun 30 2022n/an/a

-US$72m

Mar 31 2022n/an/a

-US$67m

Dec 31 2021US$2mUS$440k

-US$39m

Sep 30 2021n/an/a

-US$37m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$31m

Dec 31 2020US$782kUS$198k

-US$30m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$27m

Dec 31 2019US$1mUS$396k

-US$26m

Sep 30 2019n/an/a

-US$23m

Jun 30 2019n/an/a

-US$22m

Mar 31 2019n/an/a

-US$18m

Dec 31 2018US$452kUS$219k

-US$13m

Compensation vs Market: Bruce's total compensation ($USD684.39K) is about average for companies of similar size in the US market ($USD575.90K).

Compensation vs Earnings: Bruce's compensation has been consistent with company performance over the past year.

CEO

Bruce Steel (59 yo)

19.9yrs
Tenure
US$684,392
Compensation

Mr. Bruce D. Steel serves as Strategic Advisory Board at CR Group L.P. Mr. Steel is a co-founder, Chief Executive Officer of Equillium, Inc. since January 1, 2020, and serves as its Director since March 20...

Leadership Team

NamePositionTenureCompensationOwnership
Bruce Steel
Co-Founder19.9yrsUS$684.39k6.1%
$ 6.0m
Stephen Connelly
Chief Scientific Officer & President7.9yrsUS$519.43k1.63%
$ 1.6m
Christine Zedelmayer
Senior VP & COO7.8yrsUS$506.24k0.15%
$ 147.2k
Penny Tom
Senior VP of Finance & Principal Accounting Officerno datano data0.011%
$ 10.5k
Michael Moore
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Lisette Acevedo
Vice President of Clinical Developmentno datano datano data
7.9yrs
Average Tenure
55yo
Average Age

Experienced Management: EQ's management team is seasoned and experienced (7.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Bruce Steel
Co-Founder8.8yrsUS$684.39k6.1%
$ 6.0m
Daniel Bradbury
Chairman of the Board8.8yrsUS$189.98k3.08%
$ 3.0m
Martha Demski
Independent Director7.3yrsUS$89.29k0.039%
$ 38.3k
Thomas Daniel
Member of Scientific & Clinical Advisory Board6.6yrsno datano data
Brian Gordon Feagan
Member of Scientific & Clinical Advisory Boardless than a yearno datano data
Mark Pruzanski
Independent Director7.3yrsUS$74.29k0.039%
$ 38.3k
Vijay Kuchroo
Member of Scientific & Clinical Advisory Boardno datano datano data
Peter Colabuono
Director1yrUS$22.37k0%
$ 0
Barbara Troupin
Independent Director3.8yrsUS$67.37k0%
$ 0
Charles McDermott
Independent Director7.3yrsUS$71.79k0.039%
$ 38.3k
Fred Ramsdell
Member of Scientific & Clinical Advisory Boardno datano datano data
Francisco Quintana
Member of Scientific & Clinical Advisory Boardless than a yearno datano data
6.9yrs
Average Tenure
61.5yo
Average Age

Experienced Board: EQ's board of directors are considered experienced (6.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 00:34
End of Day Share Price 2025/12/24 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Equillium, Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Biren AminJefferies LLC
Roger SongJefferies LLC
Catherine NovackJonesTrading Institutional Services, LLC